- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.5B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.65B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.64B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.27B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.8B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.53B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.52B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.28B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $788.29M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.19B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 474.23M sh |
| Stock Repurchased restated | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $3.03M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$70.4M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $830.98M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $840.31M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $174.25M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$142.57M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$138.84M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $710.07M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.17B |